Major histocompatibility complex class II–peptide–T cell receptor complex (MHC class II–peptide–TCR complex)

The **MHC class II–peptide–T cell receptor complex** is the central molecular assembly by which **CD4+ T cells** recognize peptide antigens presented on the surface of specialized antigen-presenting cells (APCs) such as dendritic cells, macrophages, and B cells[2][6]. The MHC class II molecule presents peptides that are typically derived from extracellular proteins; these peptides include a core nine-amino acid binding motif with variable flanking regions. The *T cell receptor* (TCR), expressed on the T cell surface, engages the peptide–MHC class II combination in a highly specific interaction, which subsequently leads to T cell activation and the immune response[2][5][7]. The structural configuration of the pMHC–TCR complex is critical for antigen specificity, self/non-self discrimination, and the initiation of downstream immune signaling. Dysregulation or aberrant interactions in this complex can contribute to **autoimmune diseases**, **infectious diseases**, **cancer immunosurveillance**, and clinical complications in immunotherapy[6][7][8][9]. Therapeutic modulation of this complex is an area of active clinical development, although direct targeting poses significant safety and specificity challenges.

Other names

pMHCII–TCR complexMHC class II–antigen–TCR complexPeptide–MHC class II–TCRTCR–pMHCII complex

Inhibition of antigen recognition Blockade of TCR signaling Immune tolerance induction Alteration of T cell activation thresholds